Mitochondrial fission-fusion is important for maintaining the integrity of these organelles through the intermixing of mitochondrial constituents, thereby facilitating ongoing replacement of damaged components, including mitochondrial DNA (Chen et al., 2010) . This process also permits equal partitioning of mitochondria during mitosis, mitochondrial replication, repair of defective mitochondria, selective elimination of depolarized mitochondria via mitophagy, and propagation of intramitochondrial calcium waves. Defects in mitochondrial fissionfusion regulators frequently result in cell death because of mitochondrial dysfunction (reviewed in Detmer and Chan, 2007) . Despite the importance of this process, the mechanistic details of the regulation of mitochondrial fission-fusion dynamics remains poorly understood. Using a cell-free approach to study the fusion of mammalian mitochondria in vitro, Nunnari and colleagues now provide compelling evidence in a study published in Molecular Cell to support the idea that a subset of the apoptosisrelated Bcl-2 family does double duty as regulators of mitochondrial fusion (Hoppins et al., 2011) .
Mitochondrial fusion is governed by mitochondrial membrane-associated GTPases that promote the tethering of adjacent mitochondria, followed by fusion of their inner and outer membranes (Figure 1 ). Mitofusin 1 (Mfn1) and Mfn2 play prominent roles in this process through engaging in homo-as well as heterotypic interactions on adjacent mitochondria. Mfn1 and Mfn2 are localized to mitochondrial outer membranes, where regions within their C termini are thought to interact in trans between neighboring mitochondria to promote tethering and fusion. Another dynamin family GTPase, Opa1, which is localized to the mitochondrial inner membrane and intermembrane space, cooperates with the mitofusins in promoting mitochondrial fusion. Loss of Opa1, Mfn1, or Mfn2 leads to fragmentation of the mitochondrial network to varying degrees and results in mitochondrial dysfunction (Detmer and Chan, 2007) .
Using populations of mammalian mitochondria labeled with either green or red fluorescent proteins targeted to the mitochondrial matrix, Hoppins et al. (2011) established conditions permissive for mitochondrial fusion in vitro. Predictably, mitochondria isolated from cells lacking both Mfn1 and Mfn2 failed to undergo fusion, whereas expression of either Mfn1 or Mfn2 on both mitochondrial populations permitted fusion. However, the most efficient levels of fusion were observed when Mfn1 and Mfn2 were present on opposing mitochondria, suggesting that these proteins are nonredundant and that heterotypic Mfn1-Mfn2 interactions are more effective than homotypic ones (Hoppins et al., 2011) (Figure 1 ). Heterotypic Mfn1/Mfn2 pairings produced levels of mitochondrial fusion that were almost 3-fold greater than those observed with homotypic Mfn1/Mfn1 or Mfn2/Mfn2 combinations. A possible explanation for this observation is that interactions between Mfn1 and Mfn2 might be of greater affinity and, therefore, produce more efficient mitochondrial tethering or greater fusinogenic force than homotypic interactions. One implication of this observation is that differential expression of Mfn1 and Mfn2 in specific tissues could be sufficient to influence mitochondrial network connectivity, simply through altering the probability of formation of homotypic versus heterotypic mitofusin complexes.
Even more compelling is the authors' observation that addition of recombinant Bax-a protein that plays a central role in the propagation of pro-apoptotic signals through formation of pores in mitochondrial outer membranes-to mitochondrial preparations robustly enhanced fusion in an Mfn2-dependent manner. Significantly, mutant Bax proteins incapable of forming oligomers remained fusion competent when added to mitochondria, whereas oligomerization of Bax through addition of Bid neutralized its fusogenic properties. These observations suggest a model where soluble, monomeric Bax is capable of promoting mitochondrial fusion, a function that is compromised during apoptosis when Bax undergoes conformational changes that trigger its insertion into mitochondrial outer membranes and formation of oligomers. This model fits nicely with the observed behavior of mitochondrial networks during apoptosis, as these organelles under dramatic fission very close in time with Bax translocation to mitochondria (Karbowski et al., 2004) . Bax oligomerization within the mitochondrial outer membrane during apoptosis results in the formation of pores that permit efflux of cytochrome c from the intermembrane space, an event that plays a decisive role in the commitment to apoptosis (reviewed in Autret and Martin, 2009) . Hoppins et al. (2011) also found that another member of the Bcl-2 family, BclxL, was capable of promoting Mfn2-dependent mitochondrial fusion in vitro but at concentrations that exceeded those of endogenous Bcl-xL. Previous studies have also observed increased mitochondrial fusion upon overexpression of Bcl-xL (Sheridan et al., 2008; Berman et al., 2009) (Delivani et al., 2006; Cleland et al., 2011) . Moreover, a role for Bax as a regulator of mitochondrial fissionfusion dynamics is not without precedent. It has been shown that cells doubly deficient in Bax and its close relative, Bak, exhibit constitutively fragmented mitochondrial networks (Karbowski et al., 2006; Cleland et al., 2011) . Re-expression of Bak in these cells led to increases in mitochondrial length, suggesting that Bax and/or Bak can promote mitochondrial fusion. Mfn2 was also implicated in Bax/Bak-induced fusion, possibility through a Bax-dependent influence on the focal distribution of Mfn2 on mitochondrial membranes (Karbowski et al., 2006) . Hoppins et al. (2011) now lends further weight to these observations and to the provocative idea that members of the Bcl-2 family have an additional role as regulators of mitochondrial fusion in healthy cells (reviewed in Autret and Martin, 2009) .
While convergent lines of evidence suggest that Bax and perhaps other members of the Bcl-2 family can influence mitochondrial fissionfusion dynamics, the mechanistic details remain unresolved. Mfn2 is consistently implicated as a target for Bax, Bak, and Bcl-xL binding, but it remains possible that direct interaction with Mfn2 is not required for these effects. The process of mitochondrial membrane fusion is both complex and highly energy dependent because of the considerable repulsive forces that exist between two hydrated lipid bilayers, so-called hydration repulsion. It is plausible that the ability of members of the Bcl-2 family to insert into and perturb mitochondrial membranes lowers the threshold for membrane fusion, perhaps in conjunction with direct Mfn2 interactions. Alternatively, Bax/Bcl-xL might be involved in organizing Mfn2 molecules into foci that favor membrane fusion, as suggested by previous observations (Karbowski et al., 2006) . Whatever the precise mechanism, in vitro mitochondrial fusion assays of the type described by Hoppins et al.
(2011) will make this process considerably more amenable to detailed scrutiny.
Precisely why Bcl-2 family members participate in mitochondrial network dynamics is debatable. However, because continuous intermixing of mitochondrial constituents is important for the maintenance of healthy mitochondrial populations, it is not inconsistent that the Bcl-2 family may engage in this process as part of a quality control mechanism to ensure that mitochondrial fitness and membrane integrity is preserved. By contributing to the regulation of mitochondrial maintenance in healthy cells, Bcl-2 family proteins directly influence cell viability, a function highly compatible with their established role in cell death control. Mfn1 and Mfn2 can form homotypic and heterotypic complexes on opposing mitochondria to promote membrane tethering, followed by fusion. The data of Hoppins et al. (2011) suggest that Mfn1/Mfn2 interactions promote fusion more effectively than either Mfn1/Mfn1 or Mfn2/Mfn2 complexes. Hoppins et al. also observed that the Bcl-2 protein family members, Bax and Bcl-xL, enhanced mitochondrial fusion in an Mfn2-dependent manner. How they achieve this remains unclear.
